Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15:28 | DUALITYBIO-B (09606): FULL EXERCISE OF THE OVER-ALLOTMENT OPTION | - | HKEx | ||
00:01 | XFRA NEW INSTRUMENTS AVAILABLE ON 06.05.2025 | 119 | Xetra Newsboard | The following instruments on XETRA do have their first trading 06.05.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 06.05.2025
Aktien
1 KYG2929M1087 Duality Biotherapeutics... ► Artikel lesen | |
29.04. | DUALITYBIO-B (09606): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | - | HKEx | ||
29.04. | DUALITYBIO-B (09606): EXEMPTION UNDER RULE 13.46(2) OF THE LISTING RULES REGARDING 2024 ANNUAL REPORT | - | HKEx | ||
24.04. | Chinese Biopharma Firms Chase Hong Kong IPO, After DualityBio's Sizzling Debut | 1 | Benzinga.com | ||
15.04. | Irrer Börsengang: BioNTech-Partner DualityBio explodiert am ersten Handelstag | 2.911 | Der Aktionär | Die Börse in Hongkong ist seit dem heutigen Mittwoch um ein Biotech-Unternehmen reicher. Duality Biotherapeutics (DualityBio) hat einen furiosen Start auf das Parkett gezaubert - nicht zuletzt dank... ► Artikel lesen | |
15.04. | DUALITYBIO-B Closes Up 116.7% to $205 | 5 | AASTOCKS | ||
DUALITY BIOTHERAPEUTICS Aktie jetzt für 0€ handeln | |||||
15.04. | BRIEF: Duality Biotherapeutics surges in Hong Kong trading debut | 2 | Bamboo Works | ||
15.04. | DUALITYBIO-B Closes Up 127.1% to $214.8 at Midday | 1 | AASTOCKS | ||
15.04. | China's Duality Biotherapeutics surges over 200% in Hong Kong trading debut | 5 | Investing.com | ||
15.04. | DUALITYBIO-B (09606.HK) Opens Up 91.3% to $181 on Debut | 1 | AASTOCKS | ||
14.04. | DUALITYBIO-B (09606): ANNOUNCEMENT OF FINAL OFFER PRICE AND ALLOTMENT RESULTS | 1 | HKEx | ||
14.04. | DualityBio-B Closes Up 82.9% to $173 on Gray Mkt | 15 | AASTOCKS | ||
14.04. | DUALITYBIO-B (09606): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
14.04. | DUALITYBIO-B (09606): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE | 1 | HKEx | ||
14.04. | DUALITYBIO-B (09606): TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE | 2 | HKEx | ||
14.04. | DUALITYBIO-B (09606): TERMS OF REFERENCE OF THE AUDIT COMMITTEE | 1 | HKEx | ||
14.04. | DUALITYBIO-B (09606): MEMORANDUM AND ARTICLES OF ASSOCIATION | 1 | HKEx | ||
07.04. | Backing from BioNTech powers ADC specialist DualityBio toward $200M Hong Kong IPO | 89 | FierceBiotech | ||
07.04. | Duality Biotherapeutics: Duality Bio Appoints Hua Mu as Global Chief Medical Officer | 325 | PR Newswire | SHANGHAI, April 7, 2025 /PRNewswire/ -- DualityBio announced today that Dr. Hua Mu has joined the company as Global Chief Medical Officer (CMO). In this role, Dr. Mu will oversee the strategic... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
QIAGEN | 37,805 | -1,16 % | Biotech Report: Qiagen behauptet, Evotec sacken ab | (shareribs.com) Frankfurt / New York 30.04.2025 - Biotech-Aktien zeigten sich im deutschen Handel überwiegend fest. Für Qiagen ging es nach oben, Biontech und Evotec gaben nach. An der Wall Street konnte... ► Artikel lesen | |
EVOTEC | 7,288 | -2,57 % | Evotec Aktie: Kommt der Ausbruch Richtung 9,33 Euro? | Die Evotec Aktie hat in den vergangenen Wochen eine deutliche Erholung vollzogen. Bereits Mitte April, als der Kurs noch bei 5,78 Euro notierte, zeichnete sich eine Bodenbildung ab, auf die wir in unseren... ► Artikel lesen | |
TEMPUS AI | 52,48 | -2,90 % | Tempus AI (TEM) Stock Lower Ahead Of Q1 Earnings Report, Notetaker AI Debut | ||
BIONTECH | 82,25 | -7,89 % | BioNTech, MBB, Nagarro, Nel ASA, Rheinmetall, ThyssenKrupp, TUI - 4investors Aktien Top-News | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
SPRINGWORKS THERAPEUTICS | 46,205 | -0,01 % | Übernahme von Springworks Therapeutics: S&C und Goodwin beraten zu Merck-Deal | ||
PASITHEA THERAPEUTICS | 1,505 | +4,51 % | Pre-market Movers: Marin Software, Pasithea Therapeutics, China SXT Pharmaceuticals, Tactile Systems Technology, ThredUp | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 09.00 A.M. ET).In the Green Marin Software Incorporated (MRIN) is up over 141%... ► Artikel lesen | |
RECURSION PHARMACEUTICALS | 4,175 | -12,20 % | Recursion Pharmaceuticals: Recursion Reports First Quarter 2025 Financial Results and Provides Business Update | Pipeline: Delivered on our commitment to a more focused R&D strategy by advancing a streamlined portfolio of 5+ clinical and preclinical programs in oncology and rare disease, while deprioritizing... ► Artikel lesen | |
CG ONCOLOGY | 22,100 | -21,55 % | JPMorgan sets CG Oncology stock overweight, $41 target | ||
SUMMIT THERAPEUTICS | 24,380 | -12,96 % | Why Summit Therapeutics Inc. (SMMT) Soared Last Week | ||
ARCELLX | 53,71 | -16,72 % | Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights | REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer... ► Artikel lesen | |
BEAM THERAPEUTICS | 16,030 | -18,96 % | Beam Therapeutics Inc. Q1 Loss Increases, Misses Estimates | WASHINGTON (dpa-AFX) - Beam Therapeutics Inc. (BEAM) reported Loss for its first quarter that increased from last year and missed the Street estimates.The company's bottom line totaled -$109.27... ► Artikel lesen | |
JANUX THERAPEUTICS | 25,795 | -13,21 % | Janux Therapeutics, Inc. (JANX): Among Unknown Billionaire Phill Gross' Stock Picks with Huge Upside Potential | ||
REGENCELL BIOSCIENCE | 198,07 | +106,32 % | Pre-market Movers: Regencell Bioscience, Bakkt Holdings, Sarepta Therapeutics, Harrow, Inc., InnovAge | HONG KONG (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.30 A.M. ET).In the Green Regencell Bioscience Holdings Limited (RGC) is... ► Artikel lesen | |
ARCUTIS BIOTHERAPEUTICS | 14,650 | -5,02 % | Arcutis Biotherapeutics, Inc.: Arcutis Announces Chief Financial Officer Transition | WESTLAKE VILLAGE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations... ► Artikel lesen | |
FOXO TECHNOLOGIES | 1,540 | +130,57 % | FOXO Reaches Key Milestone, Shares Pop |